Generic name |
certolizumab |
---|---|
Strength |
200 mg/mL |
Form | subcutaneous injection solution |
Special Authority criteria |
Approval period |
---|---|
Ankylosing spondylitis | |
For the treatment of Ankylosing Spondylitis when prescribed by a rheumatologist AND when prescribed according to established criteria (as indicated on the Special Authority form below). |
First approval: 1 year Renewal: 1 year or indefinite |
Psoriatic arthritis | |
For the treatment of psoriatic arthritis when prescribed by a rheumatologist AND when prescribed according to established criteria (as indicated on the Special Authority form below). |
First approval: 1 year Renewal: 1 year or indefinite |
Rheumatoid arthritis | |
For the treatment of rheumatoid arthritis when prescribed by a rheumatologist AND when prescribed according to established criteria (as indicated on the relevant Special Authority form below). |
First approval: 1 year Renewal: 1 year or indefinite |